Literature DB >> 17690887

Central nervous system involvement as a major manifestation of rheumatoid arthritis.

M Zolcinski1, S Bazan-Socha, G Zwolinska, J Musial.   

Abstract

A 58-year-old woman with an 8-year history of seropositive rheumatoid arthritis was admitted with right hemiparesis, history of seizures, fever, weight loss and headaches. Her blood tests revealed the presence of rheumatoid factor, elevated C-reactive protein and anti-cyclic citrullinated peptide antibodies (>200 RU/ml). Examination of cerebrospinal fluid demonstrated pleocytosis (118 cells/mm(3), predominantly lymphocytes) with elevated protein level (58 mg/dl); cultures were negative. Magnetic resonance imaging findings were suggestive for meningoencephalitis. Short course of high-dose corticosteroids and cyclophosphamide led to clinical improvement. Rheumatoid vasculitis was probably responsible for neurological symptoms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17690887     DOI: 10.1007/s00296-007-0428-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  9 in total

1.  Rheumatoid disease of the CNS with meningeal vasculitis presenting with a seizure.

Authors:  L Neamtu; M Belmont; D C Miller; P Leroux; H Weinberg; D Zagzag
Journal:  Neurology       Date:  2001-03-27       Impact factor: 9.910

2.  Multiple central nervous system lesions associated with rheumatoid arthritis.

Authors:  Yasutaka Tajima; Ri-ichiro Kishimoto; Kazumasa Sudoh; Akihisa Matsumoto
Journal:  Arch Neurol       Date:  2004-11

3.  An unusual presentation of rheumatoid meningitis.

Authors:  Vaidehi Chowdhry; Neeraj Kumar; Daniel H Lachance; Diva R Salomao; Harvinder S Luthra
Journal:  J Neuroimaging       Date:  2005-07       Impact factor: 2.486

4.  Clinical significance of low titer anti-nuclear antibodies in early rheumatoid arthritis: implications on the presentation and long-term course of the disease.

Authors:  D Caspi; O Elkayam; M Eisinger; N Vardinon; M Yaron; M Burke
Journal:  Rheumatol Int       Date:  2001-02       Impact factor: 2.631

Review 5.  How to diagnose and treat secondary forms of vasculitis.

Authors:  Raashid Ahmed Luqmani; Sanjay Pathare; Tony Lee Kwok-Fai
Journal:  Best Pract Res Clin Rheumatol       Date:  2005-04       Impact factor: 4.098

Review 6.  The neuropathology of rheumatoid disease.

Authors:  R C Kim; G H Collins
Journal:  Hum Pathol       Date:  1981-01       Impact factor: 3.466

7.  Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis.

Authors:  D G Scott; P A Bacon
Journal:  Am J Med       Date:  1984-03       Impact factor: 4.965

8.  Combined suppressive drug treatment in severe refractory rheumatoid disease: an analysis of the relative effects of parenteral methylprednisolone, cyclophosphamide, and sodium aurothiomalate.

Authors:  M T Walters; M I Cawley
Journal:  Ann Rheum Dis       Date:  1988-11       Impact factor: 19.103

9.  Rheumatoid nodulosis of the meninges.

Authors:  N E Karam; L Roger; L L Hankins; J D Reveille
Journal:  J Rheumatol       Date:  1994-10       Impact factor: 4.666

  9 in total
  5 in total

Review 1.  Anti-cyclic citrullinated peptide antibody in the cerebrospinal fluid in patients with rheumatoid arthritis who have central nervous system involvement.

Authors:  Misako Higashida-Konishi; Keisuke Izumi; Masako Tsukamoto; Hiroaki Ohya; Nozomi Takasugi; Satoshi Hama; Yutaro Hayashi; Mari Ushikubo; Kumiko Akiya; Araki Kazuhiro; Yutaka Okano; Hisaji Oshima
Journal:  Clin Rheumatol       Date:  2020-04-30       Impact factor: 2.980

2.  Rheumatoid vasculitis: early presentation of rheumatoid arthritis.

Authors:  Yasir Abdulqader; Muhsen Al-Ani; Konstantinos Parperis
Journal:  BMJ Case Rep       Date:  2016-11-08

Review 3.  Rheumatoid vasculitis: vanishing menace or target for new treatments?

Authors:  Christie M Bartels; Alan J Bridges
Journal:  Curr Rheumatol Rep       Date:  2010-12       Impact factor: 4.592

4.  Assessment of biocorrelates for brain involvement in female patients with rheumatoid arthritis.

Authors:  Sherifa A Hamed; Zahra I Selim; Amal M Elattar; Yasser M Elserogy; Eman A Ahmed; Hanan O Mohamed
Journal:  Clin Rheumatol       Date:  2011-06-22       Impact factor: 2.980

5.  Refractory rheumatoid vasculitis.

Authors:  Ashok Kumar; Anshul Goel; Mehul Lapsiwala; Suman Singhal
Journal:  Oxf Med Case Reports       Date:  2016-11-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.